Association of genital human papillomavirus infection with HIV acquisition: A systematic review and meta-analysis

Sexually Transmitted Infections

Volumn 89, Issue 5, 2013, Pages 350-356

  Lissouba, Pascale ^a   Van De Perre, Philippe ^b,c,d   Auvert, Bertran ^a,e,f,g  

^a CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^b UMR 1058 University of Montpellier   (France)

^c UNIV MONTPELLIER   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA SOUTH OF THE SAHARA; AGE; ARTICLE; CIRCUMCISION; CONDOM USE; DISEASE ASSOCIATION; FOLLOW UP; GENOTYPE; HERPES SIMPLEX VIRUS 2; HETEROSEXUALITY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW RISK POPULATION; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW; FEMALE; FRANCE; IMMUNOLOGY; INCIDENCE; MALE; META ANALYSIS; REVIEW; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE; VIROLOGY; VIRUS REPLICATION;

FEMALE; FRANCE; GENOTYPE; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRUS INFECTIONS; SEXUALLY TRANSMITTED DISEASES; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 84884183894     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2011-050346     Document Type: Article

References (50)

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17. (Pubitemid 29117474)
2. Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-saharan Africa: systematic overview of 68 epidemiological studies. PLoS ONE 2007;2:e1001.
3. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009;9:118-29.
4. Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS 2010;5:305-10.
5. White RG, Orroth KK, Glynn JR, et al. Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr 2008;47:346-53.
6. Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005;32:351-7. (Pubitemid 40727179)
7. Hayes R, Watson-Jones D, Celum C, et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? Aids 2010;24(Suppl 4):S15-26.
8. de Jong MA, Geijtenbeek TB. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 2009;265:18-28.
9. Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res 2010;85:276-85.
10. Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. Journal of Clinical Virology 2005;32(Suppl 1):S16-24. (Pubitemid 40332585)
11. Tota JE, Chevarie-Davis M, Richardson LA, et al. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Preventive Medicine 2011;53(Suppl 1):S12-21.
12. Veldhuijzen NJ, Snijders PJ, Reiss P, et al. Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 2010;10:862-74.
13. WHO-ICO. Human papillomavirus and related cancers: summary report update. Barcelona: Information Centre on HPV and Cervical Cancer, 2010.
14. Woodhall S, Ramsey T, Cai C, et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008;84:161-6. (Pubitemid 351871484)
15. Pirotta M, Ung L, Stein A, et al. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 2009;85:508-13.
16. Bruni L, Diaz M, Castellsagué X, et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202:1789-99.
17. Smith JS, Gilbert PA, Melendy A, et al. Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health 2011;48:540-52.
18. Ng'ayo MO, Bukusi E, Rowhani-Rahbar A, et al. Epidemiology of human papillomavirus infection among fishermen along Lake Victoria Shore in the Kisumu District, Kenya. Sex Transm Infect 2008;84:62-6. (Pubitemid 351195856)
19. Ng'andwe C, Lowe JJ, Richards PJ, et al. The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. BMC Infect Dis 2007;7:77.
20. Didelot-Rousseau MN, Nagot N, Costes-Martineau V, et al. Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. Br J Cancer 2006;95:355-62. (Pubitemid 44187597)
21. Safaeian M, Kiddugavu M, Gravitt PE, et al. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008;17:1300-7.
22. Marais DJ, Passmore JA, Denny L, et al. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa. J Med Virol 2008;80:953-9. (Pubitemid 351657004)
23. Yamada R, Sasagawa T, Kirumbi LW, et al. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 2008;80:847-55. (Pubitemid 351500033)
24. Banura C, Franceschi S, van Doorn LJ, et al. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala, Uganda. Int J Cancer 2008;123:2180-7.
25. Rowhani-Rahbar A, Hawes SE, Sow PS, et al. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 2007;196:887-94. (Pubitemid 47378939)
26. Kahesa C, Mwaiselage J, Wabinga HR, et al. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BMC Public Health 2008;8:262.
27. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 2002;55:19-24. (Pubitemid 34123926)
28. Herfs M, Hubert P, Moutschen M, et al. Mucosal junctions: open doors to HPV and HIV infections? Trends Microbiols 2011;19(3):114-20.
29. Nicol AF, Fernandes AT, Grinsztejn B, et al. Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infected women: influence of HIV-1 coinfection. Diagn Mol Pathol 2005;14:39-47. (Pubitemid 40283861)
30. Leong CM, Doorbar J, Nindl I, et al. Deregulation of E-cadherin by human papillomavirus is not confined to high-risk, cancer-causing types. Br J Dermatol 2010;163:1253-63.
31. Leong CM, Doorbar J, Nindl I, et al. Loss of epidermal Langerhans cells occurs in human papillomavirus alpha, gamma, and mu but not beta genus infections. J Invest Dermatol 2010;130:472-80.
32. van der Loeff MF, Nyitray AG, Giuliano AR. HPV vaccination to prevent HIV infection: time for randomized controlled trials. Sex Transm Dis 2011;38:640-3.
33. Spitzer M, Brennessel D, Seltzer VL, et al. Is human papillomavirus- related disease an independent risk factor for human immunodeficiency virus infection? Gynecol Oncol 1993;49(2):243-6. (Pubitemid 23169999)
34. Harper DM. Currently approved prophylactic HPV vaccines. Expert Rev Vaccines 2009;8:1663-79.
35. Centers for Disease Control. Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60:1705-08.
36. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097.
37. von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies. Ann Intern Med 2007;147:573-7. (Pubitemid 351664504)
38. Smith-McCune KK, Shiboski S, Chirenje MZ, et al. Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections. PLoS One 2010;5(4):e10094.
39. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Bmj 2003;327:557-60. (Pubitemid 37088507)
40. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
41. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
42. Chin-Hong PV, Husnik M, Cranston RD, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. Aids 2009;23:1135-42.
43. Veldhuijzen NJ, Vyankandondera J, van de, et al. HIV acquisition is associated with prior high-risk human papillomavirus infection among high-risk women in Rwanda. Aids 2010;24:2289-92.
44. Averbach SH, Gravitt PE, Nowak RG, et al. The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. Aids 2010;24:1035-42.
45. Smith JS, Moses S, Hudgens MG, et al. Increased risk of HIV acquisition among Kenyan men with human papillomavirus infection. J Infect Dis 2010;201:1677-85.
46. Auvert B, Marais D, Zarca K, et al. High risk HPV infection is associated with HIV acquisition among South African female sex workers. Infect Dis Obstet Gynecol 2011;2011:692012.
47. da Silva GK, Guimaraes R, Mattevi VS, et al. The role of mannose-binding lectin gene polymorphisms in susceptibility to HIV-1 infection in Southern Brazilian patients. Aids 2011;25:411-18.
48. Van de Perre P, Segondy M, Foulongne V, et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 2008;8:490-7. (Pubitemid 352005823)
49. Giuliano AR, Nielson CM, Flores R, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196:1146-52. (Pubitemid 47580269)
50. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007;107(2 Suppl 1):S2-5. (Pubitemid 47559075)